True adherence data, streamlined
Recent Posts
- Cortado Ventures Doubleshot Newsletter: October 2022
- Cortado Ventures Doubleshot Newsletter: September 2022
- Moat Biotechnology Forms To Develop Novel Mucosal Vaccines for Covid-19 and Beyond: Announces Initial Funding Round and Promising Phase I trial results for Intranasal Covid-19 Vaccine
- Cortado Ventures Doubleshot Newsletter: August 2022
- Cortado Ventures Starting Second Close at $40M for Fund II